Prognostic Factors and Management Strategies in Status Epilepticus

Status epilepticus (SE) represents a neurological emergency in which seizure activity persists beyond a critical duration or recurs without recovery of consciousness. Prognostic factors span patient demographics, underlying aetiologies and initial clinical state. Advanced age, comorbidities such as stroke or brain tumours, impaired level of consciousness at onset and certain electroencephalographic patterns each portend a poorer outcome. Biomarkers of systemic inflammation have also emerged as independent predictors of mortality and functional decline. Management strategies are structured in successive tiers: urgent benzodiazepine administration as first-line therapy, prompt escalation to second-line antiseizure medications and, for refractory SE (failure to respond to two medication lines), the introduction of intravenous anaesthetic agents. In super-refractory cases, immunotherapies, targeted neuromodulation or tailored neurocritical care bundles may improve survival and long-term recovery. Early risk stratification guides intensity of monitoring, incorporation of neurocritical interventions and rehabilitation planning, thereby optimising both short-term seizure control and long-term neurological function.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Prognostic Factors and Management Strategies in Status Epilepticus publication trend

The graph below shows the total number of articles in prognostic factors and management strategies in status epilepticus across all publications each year (not limited to Nature Index journals).

Technical terms

Status epilepticus: A medical emergency defined by a seizure lasting longer than five minutes or by recurrent seizures without full recovery of consciousness.

Convulsive status epilepticus: SE characterised by overt motor manifestations, typically bilateral tonic-clonic activity.

Non-convulsive status epilepticus: SE without prominent motor symptoms, often recognised only by altered mental status and electroencephalography.

Refractory status epilepticus: Persistent seizure activity despite administration of first-line benzodiazepines and at least one second-line antiseizure medication.

Nomogram: A graphical prediction tool that integrates multiple clinical variables to estimate an individual patient’s risk of a specified outcome.

References

1. Sex-related differences in adult patients with status epilepticus: a seven-year two-center observation. Critical Care (2023).
2. Development and validation of a nomogram to provide individualized predictions of functional outcomes in patients with convulsive status epilepticus at 3 months: The modified END‐IT tool. CNS Neuroscience & Therapeutics (2023).
3. Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database. Brain Communications (2023).